The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> April 22, 2016

Interview with the President and CEO: Second Sight Medical Products Inc. (NASDAQ:EYES)

McGuire, Will
Will McGuire, President and Chief Executive Officer of Second Sight Medical Products, Inc., joined the company in August 2015 from Volcano Corporation, where he was President of Americas Commercial since 2014. Previously, since 2013, he was Senior Vice President and General Manager of Coronary Imaging, Systems and Program Management, and prior to that position, Mr. McGuire served as Vice President and General Manager of Patient Monitoring at Covidien. He previously served as President and Chief Executive Officer of AtheroMed, Inc., a venture-capital-backed peripheral atherectomy company, prior to which he was Chief Operating Officer at Spectranetics Corporation, a publicly traded medical device company. In addition, Mr. McGuire held various positions at Guidant Corporation from 1998 to 2005, including General Manager of Guidant Latin America; Director of U.S. Marketing for Vascular Intervention, or VI; Director of Global Marketing for VI; and Production Manager for Coronary Stents. Prior to 1998, Mr. McGuire held positions in finance and production at IVAC Medical Systems. A graduate of the Georgia Institute of Technology, Mr. McGuire received his MBA from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill. Profile
TWST: Let's start by introducing the company to readers with a bit of Second Sight's history and a snapshot of your business today.

Mr. McGuire: Second Sight is

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy